These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 33905426)

  • 1. Demographics and outcomes of hepatitis B and D: A 10-year retrospective analysis in a Swiss tertiary referral center.
    Vieira Barbosa J; Sahli R; Aubert V; Chaouch A; Moradpour D; Fraga M
    PLoS One; 2021; 16(4):e0250347. PubMed ID: 33905426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis D virus infection, cirrhosis and hepatocellular carcinoma in The Gambia.
    Mahale P; Aka P; Chen X; Pfeiffer RM; Liu P; Groover S; Mendy M; Njie R; Goedert JJ; Kirk GD; Glenn JS; O'Brien TR
    J Viral Hepat; 2019 Jun; 26(6):738-749. PubMed ID: 30661282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High rates of cirrhosis and severe clinical events in patients with HBV/HDV co-infection: longitudinal analysis of a German cohort.
    Bockmann JH; Grube M; Hamed V; von Felden J; Landahl J; Wehmeyer M; Giersch K; Hall MT; Murray JM; Dandri M; Lüth S; Lohse AW; Lütgehetmann M; Schulze Zur Wiesch J
    BMC Gastroenterol; 2020 Jan; 20(1):24. PubMed ID: 32000689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis.
    Stockdale AJ; Kreuels B; Henrion MYR; Giorgi E; Kyomuhangi I; de Martel C; Hutin Y; Geretti AM
    J Hepatol; 2020 Sep; 73(3):523-532. PubMed ID: 32335166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis D: A Review.
    Negro F; Lok AS
    JAMA; 2023 Dec; 330(24):2376-2387. PubMed ID: 37943548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis Delta Virus Infection in Romania: Prevalence and Risk Factors.
    Gheorghe L; Csiki IE; Iacob S; Gheorghe C; Trifan A; Grigorescu M; Motoc A; Suceveanu A; Curescu M; Caruntu F; Sporea I; Brisc C; Rogoveanu I; Cerban R; Tugui L; Alexandrescu A
    J Gastrointestin Liver Dis; 2015 Dec; 24(4):413-21. PubMed ID: 26697566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea.
    Kim HS; Kim SJ; Park HW; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Med Virol; 2011 Jul; 83(7):1172-7. PubMed ID: 21541950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A population-based study of hepatitis D virus as potential risk factor for hepatocellular carcinoma.
    Ji J; Sundquist K; Sundquist J
    J Natl Cancer Inst; 2012 May; 104(10):790-2. PubMed ID: 22423008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hepatitis delta virus (HDV) infection in chronic hepatitis B patients in eastern Turkey: still a serious problem to consider.
    Bahcecioglu IH; Aygun C; Gozel N; Poyrazoglu OK; Bulut Y; Yalniz M
    J Viral Hepat; 2011 Jul; 18(7):518-24. PubMed ID: 20546500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trial.
    Ive P; MacLeod W; Mkumla N; Orrell C; Jentsch U; Wallis CL; Stevens W; Wood R; Sanne I; Bhattacharya D
    PLoS One; 2013; 8(12):e74900. PubMed ID: 24324573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of the hepatitis Delta virus on the pathogenesis of hepatic cirrhosis and hepatocellular carcinoma. Recent advances].
    Romeo R
    Recenti Prog Med; 2010 Feb; 101(2):52-6. PubMed ID: 20433000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of hepatitis D virus infection in development of hepatocellular carcinoma among chronic hepatitis B patients treated with nucleotide/nucleoside analogues.
    Jang TY; Wei YJ; Liu TW; Yeh ML; Liu SF; Hsu CT; Hsu PY; Lin YH; Liang PC; Hsieh MH; Ko YM; Tsai YS; Chen KY; Lin CC; Tsai PC; Wang SC; Huang CI; Lin ZY; Chen SC; Chuang WL; Huang JF; Dai CY; Huang CF; Yu ML
    Sci Rep; 2021 Apr; 11(1):8184. PubMed ID: 33854160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis delta-associated mortality in HIV/HBV-coinfected patients.
    Béguelin C; Moradpour D; Sahli R; Suter-Riniker F; Lüthi A; Cavassini M; Günthard HF; Battegay M; Bernasconi E; Schmid P; Calmy A; Braun DL; Furrer H; Rauch A; Wandeler G;
    J Hepatol; 2017 Feb; 66(2):297-303. PubMed ID: 27746337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: The Hepatitis Delta International Network (HDIN).
    Wranke A; Pinheiro Borzacov LM; Parana R; Lobato C; Hamid S; Ceausu E; Dalekos GN; Rizzetto M; Turcanu A; Niro GA; Lubna F; Abbas M; Ingiliz P; Buti M; Ferenci P; Vanwolleghem T; Hayden T; Dashdorj N; Motoc A; Cornberg M; Abbas Z; Yurdaydin C; Manns MP; Wedemeyer H; Hardtke S;
    Liver Int; 2018 May; 38(5):842-850. PubMed ID: 28963781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of HBV-HDV co-infection on HBV-HCC co-recurrence in patients undergoing living donor liver transplantation.
    Baskiran A; Akbulut S; Sahin TT; Koc C; Karakas S; Ince V; Yurdaydin C; Yilmaz S
    Hepatol Int; 2020 Sep; 14(5):869-880. PubMed ID: 32895876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis delta genotype 5 is associated with favourable disease outcome and better response to treatment compared to genotype 1.
    Spaan M; Carey I; Bruce M; Shang D; Horner M; Dusheiko G; Agarwal K
    J Hepatol; 2020 Jun; 72(6):1097-1104. PubMed ID: 31981726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features of hepatitis D.
    Farci P; Niro GA
    Semin Liver Dis; 2012 Aug; 32(3):228-36. PubMed ID: 22932971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical course and outcomes of chronic viral hepatitis D in patients from Republic of Tuva as endemic region].
    Isaeva OV; Il'chenko LY; Saryglar AA; Karlsen AA; Kyuregyan KK; Mikhailov MI
    Vopr Virusol; 2021 Mar; 66(1):74-83. PubMed ID: 33683068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The medical impact of hepatitis D virus infection in Uzbekistan.
    Khodjaeva M; Ibadullaeva N; Khikmatullaeva A; Joldasova E; Ismoilov U; Colombo M; Caviglia GP; Rizzetto M; Musabaev E
    Liver Int; 2019 Nov; 39(11):2077-2081. PubMed ID: 31505080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low Incidence of Adverse Outcomes in Adults With Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy.
    Lok AS; Perrillo R; Lalama CM; Fried MW; Belle SH; Ghany MG; Khalili M; Fontana RJ; Sterling RK; Terrault N; Feld JJ; Di Bisceglie AM; Lau DTY; Hassan M; Janssen HLA;
    Hepatology; 2021 Jun; 73(6):2124-2140. PubMed ID: 32936969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.